Published March 19, 2022 | Version v1
Journal article Open

Antibody Characterization Report for Charged multivesicular body protein 2b


Head-to-head comparison of available commercial antibodies against Charged multivesicular body protein 2b by immunoblot (Western blot), immunoprecipitation and immunofluorescence. The workflow and data collected in this study was used to create an article published on F1000, DOI: 10.12688/f1000research.139755.1.

Work reported in this report was supported in part by the ALS-Reproducible Antibody Platform (ALS-RAP). ALS-RAP was created as a public-private partnership by three leading ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.


Charged multivesicular body protein 2b_CHMP2B_YCharOS report-v2.pdf

Files (2.4 MB)